Popular Weight-Loss drugs may pose hidden surgery risk
NCT ID NCT06500143
Summary
This study looked at whether popular diabetes and weight-loss medications (called GLP-1 agonists) might leave too much food or liquid in a person's stomach before scheduled surgery, even if they stop the medication a week in advance as recommended. Researchers used a quick ultrasound scan to compare stomach contents in 94 people who were taking these drugs to those who were not. The goal was to gather information to improve safety guidelines for patients needing surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC RETENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIUSSS de l'Est de l'Ile de Montréal
Montreal, Quebec, H1T2M4, Canada
Conditions
Explore the condition pages connected to this study.